Prevention of Gastrointestinal Toxicity from total body irradation or high dose Chemo with SOM230
Research Grant
Administered By
Duke Cancer Institute
Awarded By
Novartis Pharmaceuticals Corporation
Start Date
December 1, 2013
End Date
July 15, 2021
Administered By
Duke Cancer Institute
Awarded By
Novartis Pharmaceuticals Corporation
Start Date
December 1, 2013
End Date
July 15, 2021